Journal article icon

Journal article

Evaluating glomerular filtration rate slope as a surrogate endpoint for ESKD in clinical trials: an individual participant meta-analysis of observational data

Abstract:

Background: Decline in eGFR is a biologically plausible surrogate end point for the progression of CKD in clinical trials. However, it must first be tested to ensure strong associations with clinical outcomes in diverse populations, including patients with higher eGFR.
Methods: To investigate the association between 1-, 2-, and 3-year changes in eGFR (slope) with clinical outcomes over the long term, we conducted a random effects meta-analysis of 3,758,551 participants with baseline eGFR≥60 ml/min per 1.73 m2 and 122,664 participants with eGFR<60 ml/min per 1.73 m2 from 14 cohorts followed for an average of 4.2 years.
Results: Slower eGFR decline by 0.75 ml/min per 1.73 m2 per year over 2 years was associated with lower risk of ESKD in participants with baseline eGFR≥60 ml/min per 1.73 m2 (adjusted hazard ratio, 0.70; 95% CI, 0.68 to 0.72) and eGFR<60 ml/min per 1.73 m2 (0.71; 95% CI, 0.68 to 0.74). The relationship was stronger with 3-year slope. For a rapidly progressing population with predicted 5-year risk of ESKD of 8.3%, an intervention that reduced eGFR decline by 0.75 ml/min per 1.73 m2 per year over 2 years would reduce the ESKD risk by 1.6%. For a hypothetical low-risk population with a predicted 5-year ESKD risk of 0.58%, the same intervention would reduce the risk by only 0.13%.
Conclusions: Slower decline in eGFR was associated with lower risk of subsequent ESKD, even in participants with eGFR≥60 ml/min per 1.73 m2, but those with the highest risk would be expected to benefit the most.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1681/ASN.2019010008

Authors

More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Women's & Reproductive Health
Sub department:
Women's & Reproductive Health
Department:
Oxford, MSD, Womens & Reproductive Health
Role:
Author


Publisher:
American Society of Nephrology
Journal:
Journal of the American Society of Nephrology More from this journal
Volume:
30
Issue:
9
Pages:
1746-1755
Publication date:
2019-07-10
Acceptance date:
2019-04-17
DOI:
ISSN:
1533-3450


Keywords:
Pubs id:
pubs:993688
UUID:
uuid:ce644af3-ad22-442b-88b5-830950279224
Local pid:
pubs:993688
Source identifiers:
993688
Deposit date:
2019-04-23
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP